Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

GSMS Alprazolam 1mg Tablets Recalled for Potential Cross-Contamination

Agency Publication Date: March 15, 2022
Share:
Sign in to monitor this recall

Summary

Golden State Medical Supply Inc. (GSMS) is recalling 401 bottles of Alprazolam (1mg) tablets because they may have been contaminated with another drug substance during the manufacturing process. The recall affects 180-count bottles of the prescription medication manufactured by ULTRAlab Laboratories and packaged by GSMS. Consumers who have this medication should contact their healthcare provider or pharmacist immediately for guidance.

Risk

The potential cross-contamination with an unintended drug substance during manufacturing could lead to unexpected side effects or harmful interactions with other medications. No incidents or injuries have been reported in connection with this recall to date.

What You Should Do

  1. This recall affects Alprazolam Tablets, USP 1mg, packaged in 180-count bottles under the GSMS brand (NDC 60429-504-18).
  2. Check your prescription bottle for lot number GS027852 with an expiration date of 06/2022.
  3. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Golden State Medical Supply Inc. for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions regarding this recall.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Alprazolam Tablets, USP 1mg (180-count)
Variants: 1mg, Tablet
Lot Numbers:
GS027852 (Exp 06/2022)
NDC:
60429-504-18

Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GSMS, Inc., CA.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 89712
Status: Resolved
Manufacturer: Golden State Medical Supply Inc.
Sold By: wholesaler/distributor
Manufactured In: United States
Units Affected: 401 bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.